| Literature DB >> 33585556 |
Xinbing Sui1,2,3,4, Xuemeng Han2, Peng Chen2, Qibiao Wu4, Jiao Feng2, Ting Duan2, Xiaying Chen2, Ting Pan2, Lili Yan2, Ting Jin2, Yu Xiang2, Quan Gao2, Chengyong Wen2, Weirui Ma2, Wencheng Liu2, Ruonan Zhang2,3, Bi Chen2,3, Mingming Zhang2, Zuyi Yang2, Na Kong2, Tian Xie2,3, Xia Ding1.
Abstract
Baicalin, as a natural active ingredient extracted and isolated from the traditional Chinese medicine Scutellaria baicalensis Georgi., has been potentially used in various areas for its antioxidative, antitumor, anti-inflammatory, and anti-proliferative activities. Although several studies have reported the antitumor effects of baicalin against various cancer types, its beneficial effects on lung cancer have not yet been elucidated. Therefore, the therapeutic effects and molecular mechanisms of baicalin on lung cancer cell lines H1299 and H1650 were investigated. Here, the results of its antitumor activity were shown. We found that Akt/mTOR pathway inhibition was the essential determinant in baicalin-induced cell cycle arrest. Furthermore, when the Akt Agonist SC79 or Akt plasmid transfection was performed, the antitumor effect of baicalin was significantly abrogated in both H1299 and H1650 cells. In conclusion, we found that baicalin exerted its antitumor activity mainly by inducing Akt-dependent cell cycle arrest and promoting apoptosis, which show great potential for developing a new drug for lung cancer treatment.Entities:
Keywords: Akt; apoptosis; baicalin; cell cycle; lung cancer
Year: 2021 PMID: 33585556 PMCID: PMC7876332 DOI: 10.3389/fmolb.2020.602282
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X